v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue:        
Net sales $ 8,191 $ 16,443 $ 96,451 $ 90,498
Cost of sales (14,426) (19,184) (75,765) (67,701)
Gross profit (loss) (6,235) (2,741) 20,686 22,797
Operating Expenses:        
Research and development (2,520,203) (5,685,292) (5,156,535) (8,157,408)
Selling, general and administrative (3,355,790) (3,232,576) (7,956,896) (6,397,747)
Total Operating Expenses (5,875,993) (8,917,868) (13,113,431) (14,555,155)
Loss From Operations (5,882,228) (8,920,609) (13,092,745) (14,532,358)
Other Income (Expense):        
Interest income 3,340 38,603 7,014 102,282
Foreign exchange transaction loss (4,233) (55,985) (9,144) (59,206)
Interest expense, including amortization of debt discount (13,828) (5,184) (20,104)
Total Other Income (Expense) (893) (31,210) (7,314) 22,972
Loss before income taxes (5,883,121) (8,951,819) (13,100,059) (14,509,386)
Tax benefit 1,250,186 5,169,395 1,250,186 5,169,395
Net Loss (4,632,935) (3,782,424) (11,849,873) (9,339,991)
Other Comprehensive Income (Loss):        
Unrealized gain (loss) from investments (662) 13,853 (315) 8,221
Foreign currency translation gain (loss) 1,017 1,001 (2,510) 112
Total Other Comprehensive Income (Loss) 355 14,854 (2,825) 8,333
Comprehensive Loss $ (4,632,580) $ (3,767,570) $ (11,852,698) $ (9,331,658)
Net Loss Per Common Share – Basic and Diluted (in Dollars per share) $ (0.12) $ (0.14) $ (0.32) $ (0.36)
Weighted Average Common Shares Outstanding – Basic and Diluted (in Shares) 38,083,842 26,143,360 37,211,233 26,101,493